Large Vestibular Aqueduct Syndrome (LVAS) — Pediatric Sensorineural Hearing Loss
Most common radiologically identifiable cause of pediatric sensorineural hearing loss; defined as vestibular aqueduct midpoint diameter >1.5 mm or operculum diameter >2 mm on temporal bone CT, frequently associated with SLC26A4 (pendrin) gene mutations and Pendred syndrome; presents with progressive or fluctuating sensorineural hearing loss, often triggered by minor head trauma, with treatment focused on hearing aids, cochlear implantation for severe loss, and avoidance of activities that cause head trauma.
This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.
This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our KBB (Kulak Burun Boğaz) department. Book Appointment →
What is Large Vestibular Aqueduct Syndrome (LVAS) — Pediatric Sensorineural Hearing Loss?
Large vestibular aqueduct syndrome (LVAS), or enlarged vestibular aqueduct (EVA), is the most common radiographically identifiable inner ear malformation associated with childhood sensorineural hearing loss, accounting for 5–15 percent of pediatric SNHL cases. The vestibular aqueduct is a bony channel within the petrous temporal bone running from the medial wall of vestibule of inner ear to the posterior cranial fossa, encasing the endolymphatic duct that connects the endolymphatic sac (located within dura mater) to the membranous labyrinth.
Cincinnati criteria define LVAS as midpoint diameter >1.5 mm or operculum diameter >2 mm on axial high-resolution temporal bone CT. Alternative criteria propose midpoint >0.9 mm or any vestibular aqueduct larger than adjacent posterior semicircular canal as enlarged. Bilateral involvement in 50–94 percent (asymmetric in many). Frequently associated with cochlear malformations, particularly incomplete partition type II (Mondini malformation — 1.5 turns of cochlea instead of 2.5).
Genetics: strong association with SLC26A4 gene (chromosome 7q22.3) encoding pendrin, a chloride-iodide-bicarbonate anion exchanger. Biallelic SLC26A4 mutations cause Pendred syndrome (autosomal recessive), characterized by sensorineural hearing loss, thyroid goiter (often appearing in adolescence), and abnormal organification of iodide demonstrable by positive perchlorate discharge test. Monoallelic SLC26A4 mutations or biallelic with EPHA2 modifier cause non-syndromic EVA (DFNB4 locus). Other associations: branchio-oto-renal (BOR) syndrome (EYA1, SIX5 mutations), CHARGE syndrome, distal renal tubular acidosis, X-linked deafness with stapes gusher (POU3F4).
Hearing loss characteristics: bilateral in most, often asymmetric, sensorineural (rarely conductive component due to third window effect), ranges from mild to profound, may be present at birth (congenital — fail newborn hearing screening), or develop later (delayed onset). Course: progressive in 50 percent (gradual decline over months to years), fluctuating in 10–35 percent (recovers partially or fully), or sudden drops triggered by: minor head trauma (most common — fall, sports injury, even hitting head on cabinet), barotrauma (scuba diving, airplane descent), Valsalva (heavy lifting, straining), vigorous exercise, or upper respiratory infection. Vestibular symptoms (vertigo, imbalance, motion intolerance) in 30 percent.
Symptoms
Risk Factors
When to See a Doctor?
If you experience any of the following symptoms, seek medical attention promptly:
- Failed newborn hearing screening — refer to pediatric audiology and ENT
- Speech and language delay in toddler — comprehensive audiologic evaluation
- Sudden hearing drop following minor head trauma in child — emergent
- Progressive or fluctuating hearing loss in child — temporal bone imaging
- Family history of hearing loss with new pediatric symptoms
- Thyroid goiter appearing in adolescent with hearing loss (Pendred)
- Vertigo or imbalance episodes in child with hearing loss
- Concerns about activity restrictions in child with confirmed LVAS
- Hearing loss progression despite hearing aids — cochlear implantation evaluation
Treatment Methods
Which Department to Visit?
You can visit our KBB (Kulak Burun Boğaz) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.
Learn About KBB (Kulak Burun Boğaz) DepartmentLet us help you
You can make an appointment with our specialists or contact us for your concerns.
Related Health Topics
Other articles from the same department you may want to explore.
Anaemia
Dahiliye (İç Hastalıkları)
Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.
Iron Deficiency Anaemia
Dahiliye (İç Hastalıkları)
Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.
Vitamin B12 Deficiency
Dahiliye (İç Hastalıkları)
Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.
Hypertension (High Blood Pressure) Management
Dahiliye (İç Hastalıkları)
Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.
Chronic Kidney Disease
Dahiliye (İç Hastalıkları)
Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.
Hepatitis B (HBV)
Dahiliye (İç Hastalıkları)
Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.
Hepatitis C (HCV)
Dahiliye (İç Hastalıkları)
Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.
Fatty Liver Disease
Dahiliye (İç Hastalıkları)
Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.
Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.